Abstract
Benzodiazepines and other compounds which act at benzodiazepine binding sites have been shown previously to attenuate the acquisition of conditioned fear in rodents when administered before the acquisition session, an effect which may parallel the disruption of human memory produced by anxiolytics and sedatives. Such an action is usually, but not invariably, produced by doses which have direct behavioural depressant effects. The present study was carried out to extend previous work by investigating the effects of the hypnotic benzodiazepine triazolam and the nonbenzodiazepines zolpidem and CL 218,872 on the acquisition of learned fear in mice. All these drugs reduced locomotor activity shortly after injection. They also produced disruptions of the acquisition of learned fear. Triazolam exerted behavioural effects similar to those found previously with other benzodiazepines, the doses which disrupted the acquisition of conditioned fear being similar to, or lower than, the doses which depressed locomotion. In contrast, the results indicated that zolpidem was more potent at reducing locomotion than at interfering with fear conditioning, a result which may reflect the preferential sedative action of zolpidem.
Similar content being viewed by others
References
Arbilla S, Depoortere H, George P, Langer SZ (1985) Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats. Naunyn-Schmiedeberg's Arch Pharmacol 330:248–251
Broekkamp CL, LePichon M, Lloyd KG (1984) The comparative effects of benzodiazepines, progabide and PK 9084 on acquisition of passive avoidance in mice. Psychopharmacology 83:122–125
Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986) Zolpidem, a novel non-benzodiazepine hypnotic I — Neuropharmacological and behavioral effects. J Pharmacol Exp Ther (in press)
File SE, Wilks L (1985) Effects of acute and chronic treatment on the pro- and anti-convulsant actions of CL 218,872, PK 8165 and PK 9084, putative ligands for the benzodiazepine receptor. J Pharm Pharmacol 37:252–256
File SE, Pellow S, Wilks L (1985) The sedative effects of CL 218,872, like those of chlordiazepoxide, are reversed by benzodiazepine antagonists. Psychopharmacology 85:295–300
Gee KW, Yamamura HI (1982) Regional heterogeneity of benzodiazepine receptors at 37° C: an in vitro study in various regions of the rat brain. Life Sci 31:1939–1945
Gee KW, Brinton RE, Yamamura HI (1983) CL 218,872 antagonism of diazepam induced loss of righting reflex: evidence for partial agonistic activity at the benzodiazepine receptor. Life Sci 32:1037–1040
Griffiths RR, Lamb RJ, Ator NA, Roache JD, Brady JV (1985) Relative abuse liability of triazolam: Experimental assessment in animals and humans. Neurosci Biobehav Rev 9:133–151
Jensen RA, Martinez JL, Vasquez BJ, McGaugh JL (1979) Benzodiazepines alter acquisition and retention of an inhibitory avoidance response in mice. Psychopharmacology 64:125–126
Komiskey HL, Cook TM, Lin C-F, Hayton WI (1981) Impairment of learning or memory in the mature and old rat by diazepam. Psychopharmacology 73:304–305
Lippa AS, Coupet J, Greenblatt EN, Klepner CA, Beer B (1979) A synthetic non-benzodiazepine ligand for benzodiazepine receptors: a probe for investigating neuronal substrates of anxiety. Pharmacol Biochem Behav 11:99–106
Lister RG (1985) The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev 9:87–94
McElroy JF, Feldman RS (1982) Generalization between benzodiazepine-and triazolopyridazine — elicited discriminative cues. Pharmacol Biochem Behav 17:709–713
McElroy JF, Fleming RL, Feldman RS (1985) A comparison between chlordiazepoxide and CL 218,872 — a synthetic nonbenzodiazepine ligand for benzodiazepine receptors on spontaneous locomotor activity in rats. Psychopharmacology 85:224–226
Nicholson AN, Pascoe DA (1986) Hypnotic activity of an imidazopyridine (zolpidem). Bri J Clin Pharmacol 21:205–211
Oakley NR, Jones BJ, Straughan DW (1984) The benzodiazepine receptor ligand CL 218,872 has both anxiolytic and sedative properties in rodents. Neuropharmacology 23:797–802
Oishi H, Iwahara S, Yang KM, Yogi A (1972) Effects of chlordiazepoxide on passive avoidance responses in rats. Psychopharmacologia 23:373–385
Patel JB, Ciofalo VB, Ioro LC (1979) Benzodiazepine blockade of passive-avoidance task in mice: a state-dependent phenomenon. Psychopharmacology 61:25–28
Roehrs T, Zorick FJ, Sicklestell JM, Wittig RM, Hartse KM, Roth T (1983) Effects of hypnotics on memory. J Clin Psychopharmacol 3:310–313
Roth T, Hartse KM, Saab PG, Piccione PM, Kramer M (1980) The effects of flurazepam, lorazepam, and triazolam on sleep and memory. Psychopharmacology 70:231–237
Roth T, Roehrs TA, Zorick FJ (1983) Pharmacology and hypnotic efficacy of triazolam. Pharmacotherapy 3:137–145
Sanger DJ, Joly D (1985) Anxiolytic drugs and the acquisition of conditioned fear in mice. Psychopharmacology 85:284–288
Sanger DJ, Zivkovic B (1986) The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic. Psychopharmacology (in press)
Scobie S, Garske G (1970) Chlordiazepoxide and conditioned suppression. Psychopharmacologia 16:272–280
Soubrié P, Simon P, Boissier JR (1976) An amnesic effect of benzodiazepines in rats? Experientia 32:359–360
Spinweber CL, Johnson LC (1982) Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold. Psychopharmacology 76:5–12
Thiébot MH (1985) Some evidence for amnesic-like effects of benzodiazepines in animals. Neurosci Biobehav Rev 9:95–100
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sanger, D.J., Joly, D. & Zivkovic, B. Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice. Psychopharmacology 90, 207–210 (1986). https://doi.org/10.1007/BF00181243
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00181243